NOT-AI-26-007: Notice of Early Expiration of PAR-25-330, "Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)"

Notice of Early Expiration of PAR-25-330, "Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)"

Notice Number:

NOT-AI-26-007

Key Dates

Release Date:

February 19, 2026

Related Announcements

December 09, 2024 - Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed). See NOFO PAR-25-330.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that PAR-25-330, “Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)” will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO).

Inquiries

Please direct all inquiries to:

National Institute of Allergy and Infectious Diseases (NIAID)
[email protected]